<DOC>
	<DOCNO>NCT00466336</DOCNO>
	<brief_summary>The purpose prospective study evaluate value Doppler parameter compare diagnostic accuracy Doppler parameters various biochemical index predict significant hepatic fibrosis ( ≥ F2 ) cirrhosis ( F4 ) chronic hepatitis C ( CHC ) patient .</brief_summary>
	<brief_title>Prediction Hepatic Fibrosis Patients With Chronic Hepatitis C Biochemical Duplex Doppler Indices</brief_title>
	<detailed_description>Chronic hepatitis C virus ( HCV ) infection global health problem , affect 3 % world 's population . Compared patient mild hepatic fibrosis , significant fibrosis risk develop cirrhosis 10- 20-year period . This fact suggest need early antiviral therapy chronic hepatitis C ( CHC ) patient prevent development cirrhosis associate complication . For patient cirrhosis , surveillance endoscopy ultrasound gastroesophageal varix hepatocellular carcinoma need minimize morbidity mortality ) . Furthermore , reduce treatment response tolerability antiviral therapy may encounter cirrhotic patient . An accurate assessment hepatic fibrosis stage therefore important diagnostic therapeutic purpose . Liver biopsy recognize gold standard assess grade necroinflammation stage fibrosis . However , costly , harbor risk complication , include 20 % patient discomfort , 0.1-3 % significant morbidity , 0.02-0.24 % mortality . In addition , sample error due non-uniform distribution parenchymal damage , well intra- inter-observer variability often encounter . A noninvasive tool evaluate liver disease activity fibrosis stage would helpful , particularly monitoring CHC patient time . Noninvasive method evaluate hepatic histology HCV-infected patient include symptom sign , routine laboratory test , serum marker fibrosis inflammation , quantitative test liver function , radiological imaging . Previous study assess usefulness noninvasive test predict hepatic fibrosis . However , none show satisfactory result , either due lack accuracy , accessibility , reproducibility expensive . Duplex Doppler ultrasonography ( DDU ) , readily available non-invasive , used assessment splanchnic vascular hemodynamics patient chronic liver disease . Portal vein velocity ( PVV ) show correlated significant fibrosis cirrhosis . Hepatic artery resistive index ( HARI ) pulsatility index ( HAPI ) associate portal vein resistance hepatic vein-portal vein pressure gradient ( HPVG ) . Splenic artery resistive index ( SARI ) pulsatility index ( SAPI ) associate portal vein resistance , cirrhosis grade esophageal varix ( EV ) . Previous study evaluate value DDU predict liver histology controversial , probably due small patient number , diverse grade liver histology , large miss data . Thus , purpose prospective study evaluate value Doppler parameter compare diagnostic accuracy Doppler parameters various biochemical index predict significant hepatic fibrosis ( ≥ F2 ) cirrhosis ( F4 ) chronic hepatitis C ( CHC ) patient .</detailed_description>
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Hepatitis , Chronic</mesh_term>
	<mesh_term>Hepatitis C , Chronic</mesh_term>
	<mesh_term>Liver Cirrhosis</mesh_term>
	<criteria>Age old 18 year Positive antiHCV HCV RNA 6 month Alanine aminotransferase level twice upper limit normal ( ULN ) HBV HCV coinfection HIV HCV coinfection Heavy alcohol use ( &gt; 50 gram/day ) Autoimmune liver diseases Metabolic liver diseases Presence hepatocellular carcinoma</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2008</verification_date>
	<keyword>Chronic hepatitis C</keyword>
	<keyword>Non-invasive diagnosis</keyword>
	<keyword>Duplex Doppler ultrasonography</keyword>
	<keyword>Biochemical index</keyword>
	<keyword>Hepatic fibrosis</keyword>
	<keyword>Cirrhosis</keyword>
</DOC>